ivWatch has partnered with leaders in the medical device and health care space to allow institutions to reduce patient harm and improve patient safety by providing continuous monitoring technology for the early detection of IV infiltrations and extravasations.
ivWatch and Terumo entered into a licensing and distribution agreement to help improve patient safety. As part of the agreement, Terumo Corporation is named as the exclusive distributor for the ivWatch Model 400 in Japan and has licensed the ivWatch OEM board** to provide continuous IV infiltration detection technology in Terumo products globally.
ivWatch is the market leader for continuous IV infiltration and extravasation detection technology and Terumo Corporation is one of the world’s leading medical device manufacturers and distributors.
Vizient-served members can contact their Vizient account manager or access additional information on the ivWatch Model 400 through the Vizient member portal.
Premier members can contact their Premier account manager or access additional information on the ivWatch Model 400 through the Premier member portal. Please reference contract number PP-NS-1123.